Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis
about
Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple SclerosisVaricella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management.Experimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin DamageVisual detection of glial cell line-derived neurotrophic factor based on a molecular translator and isothermal strand-displacement polymerization reaction.From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis.Antidepressant activity of fingolimod in mice.Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation.
P2860
Q28080754-E71A97DB-34A0-4D73-AFAD-6C7502E4C78FQ33562804-4A7A43AF-AEEB-42D4-AF44-B77E4F637005Q33838894-0D4C942D-72E4-456B-9151-1CD4108087EEQ38890210-08FA850B-991C-4010-A075-DDBBF58DC533Q39032639-614CEACF-BD43-484C-805E-FBE0C8B1BF43Q41359968-2A21377B-4053-4F99-9ACB-A5F090966C26Q42234408-67A9F7F5-F1BF-40EC-84E5-4107A0BB4F78
P2860
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis
@en
type
label
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis
@en
prefLabel
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis
@en
P2093
P2860
P356
P1476
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis
@en
P2093
Carla Nasca
Luigi di Nuzzo
Rosamaria Orlando
P2860
P304
P356
10.2147/DDDT.S52428
P407
P5008
P577
2014-05-19T00:00:00Z